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Abstract
The amelogenesis imperfectas (AIs) are a clinically and genetically diverse group of conditions that
are caused by mutations in a variety of genes that are critical for normal enamel formation. To date,
mutations have been identified in four genes (AMELX, ENAM, KLK4, MMP20) known to be involved
in enamel formation. Additional yet to be identified genes also are implicated in the etiology of AI
based on linkage studies. The diverse and often unique phenotypes resulting from the different allelic
and non-allelic mutations in these genes provide an opportunity to better understand the role of these
genes and their related proteins in enamel formation. Understanding the AI phenotypes also provides
an aid to clinicians in directing molecular studies aimed at delineating the genetic basis underlying
these diverse clinical conditions. Our current knowledge of the known mutations and associated
phenotypes of the different AI subtypes are reviewed.
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INTRODUCTION
While many hereditary and environmental conditions are associated with abnormal enamel
formation, amelogenesis imperfecta (AI) is a term used for hereditary conditions that affect
enamel formation not associated with marked developmental defects in other tissues. Insightful
evaluation of the AI phenotypes led to a variety of classifications of these conditions and even
proposed mechanisms of the underlying pathology despite a lack of molecular evidence
[Witkop and Sauk, 1976]. Since discovery of the amelogenin gene (AMELX) [Snead et al.,
1989], the molecular basis of these conditions has progressed, albeit at a rather slow pace due
to the conditions’ genetic diversity, relative rarity, and difficulty studying a tissue where mRNA
and cell lines are not readily available. Despite these challenges, four genes have been identified
as causative of these conditions and are associated with phenotypes that in many cases confirm
developmental mechanisms previously hypothesized as responsible for the different AI
subtypes. The most commonly accepted classification of AI recognizes four major AI types
that were proposed by Carl Witkop, Jr. based on their phenotype and their proposed mechanism
of development [Witkop, 1989].
Current molecular evidence supports many of Witkop’s proposed developmental mechanisms
and their associated phenotypes [Witkop and Sauk, 1976], although the genetic heterogeneity
that has emerged is more complex than many investigators expected. This is not altogether
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surprising given our current understanding that amelogenesis (the process of enamel formation)
is an exquisitely orchestrated process involving strict genetic regulation of a variety of diverse
processes. The ameloblasts (enamel producing cells) secrete a unique extracellular matrix that
is processed by proteinases in a highly controlled fashion. They control the critical ionic and
fluid concentration of the micro-environment, regulate the pH during mineralization, are motile
and undergo tremendous morphological changes during their life cycle to accommodate these
diverse physiological functions [Simmer and Fincham, 1995; Smith, 1998].
We now know that a variety of genetic mutations are associated with distinct disturbances in
these critical processes that lead to the conditions referred to as AI. The most abundant
extracellular matrix protein in developing enamel is amelogenin [Fincham and Simmer,
1997] and mutations in the gene encoding this protein are responsible for a variety of
phenotypes ranging from deficiencies in the amount of enamel (hypoplastic AI) to defects in
the mineralization of the enamel due to aberrant processing of the matrix (hypomaturation AI)
[Wright et al., 2003]. Mutations in the ENAM gene that encodes another extracellular matrix
protein result in a variety of hypoplastic phenotypes depending on the specific mutation and
its effect on the protein [Rajpar et al., 2001; Mardh et al., 2002]. More recently, mutations in
the genes (KLK4 and MMP20) encoding two known proteinases that are considered critical for
processing of the extracellular matrix have been shown to cause defects in the final crystallite
mineralization or maturation of the enamel (autosomal recessive pigmented hypomaturation
AI; OMIM 204700) [Hart et al., 2004; Kim et al., 2005a]. The most common form of AI in
North America (autosomal dominant hypocalcified AI) has not been associated with a specific
gene and indeed evidence suggests that it is not caused by any of the known candidate AI genes
[Hart et al., 2003]. Finally, AI type IV (OMIM 104510), that is associated with an unusual
phenotype including hypoplastic enamel and elongation of the dental pulp or taurodontism,
remains controversial as being a true AI subtype [Crawford and Aldred, 1990] due to its close
and often misdiagnosed association with tricho-dento-osseous syndrome (OMIM 190320).
The best approach for correlating our current molecular understanding of AI and their
associated phenotypes in a robust and meaningful nosology has yet to be developed [Aldred
et al., 2003]. Ideally, a nosology will emerge that takes into consideration the mode of
inheritance and phenotypic features that are essential for clinical delineation of each AI type,
while also coupling these critical clinical features to our understanding of the molecular basis
of these conditions. This manuscript reviews our current knowledge about the molecular basis
of each of the AI types and their associated phenotypes. The different AI types are presented
based on their mode of inheritance as opposed to a phenotype based approach as is traditionally
used for AI as it is felt that this is clinically more relevant and is critical for patient counseling
and investigative approaches directed at identifying the molecular basis of these conditions.
X-LINKED AMELOGENESIS IMPERFECTA
All of the X-linked forms of AI (OMIM 300391) with a known molecular basis are associated
with mutations in the AMELX gene (located at chromosome Xp22) that codes for amelogenin.
One family has shown significant linkage to another X linked interval (Xq22-28) [Aldred et
al., 1992a] and there are other X-linked conditions that have significant enamel involvement
making it likely there are other genes important in enamel formation on the X chromosome
[Landy and Donnai, 1993; Mikkola and Thesleff, 2003; Balmer et al., 2004]. Amelogenin is
the predominant extracellular matrix protein in developing enamel and is thought to form an
organic scaffold through self assembly that is essential for controlling the highly ordered and
directional growth of enamel crystallites [Robinson et al., 1990; Fincham and Simmer,
1997]. Although the exact functions of the amelogenin protein have not been fully established,
its critical role in enamel development is verified by the association of enamel defects with
AMELX mutations in humans, and the presence of severe enamel hypoplasia in the amelogenin
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knock-out mouse [Gibson et al., 2001]. Human amelogenin has a 16 amino acid signal peptide,
and is secreted primarily as a 175 amino acid protein [Salido et al., 1992]. It is known that there
are alternatively spliced amelogenin proteins formed by deleting or adding certain exon
products [Simmer et al., 1994; Baba et al., 2002]. During normal enamel formation the
amelogenin protein is processed in a controlled fashion thereby generating the regulatory
mechanism considered essential for orderly crystallite growth [Hu et al., 2002]. The acidic
amelogenin C-terminus has a high mineral affinity compared with the remaining amelogenin
molecule and is rapidly cleaved after secretion of the parent protein from the ameloblasts
[Shaw et al., 2004]. During normal enamel development the amelogenin proteins are almost
completely removed allowing the enamel crystallites to grow and produce mature enamel that
is greater than 95% mineral by weight [Smith, 1998].
AMELX Mutations are Diverse and Include Deletion, Missense, and Nonsense Mutations
These coding errors result in essentially two different and sometimes overlapping phenotypes
including a deficiency in the amount of enamel (hypoplasia; OMIM 301200) and defects in
enamel mineralization (hypomaturation) [Wright et al., 2003] The enamel phenotype appears
to be related to the changes in amelogenin that vary from loss of the protein due to large
deletions, signal peptide mutations, or alteration of specific functional domains. Because
affected males will express only the mutant allele, with females showing a mosaic pattern of
expression due to X chromosome inactivation (Lyonization), the male and female phenotypes
vary markedly in severity and appearance [Witkop, 1967]. Females with AMELX mutations
typically have either discolorations or bands of hypoplasia that run vertically on the teeth due
to clusters of ameloblasts expressing either the normal or mutant AMELX allele [Hart et al.,
2002]. There are 14 AMELX mutations reported to date (Table I) which are reviewed in the
following section.
AMELX Major Deletions and Mutations in the Signal Peptide Coding Region
A 5 Kb deletion, including all genomic DNA from the beginning of exon 3 through part of
exon 7 (g.1148_47del), was the first AI associated mutation discovered [Lagerström et al.,
1991]. This represents what amounts to a human knockout of the AMELX gene with only two
amino acids beyond the signal peptide potentially being coded by the mutant gene. The
associated phenotype reported in the two Swedish families having this mutation is described
as being predominantly a hypomineralization/hypomaturation defect [Lagerström-Fermer and
Landegren, 1995]. The enamel has a mottled white opaque coloration and microradiographic
studies show that it is hypomineralized [Backman and Anneroth, 1989]. There also is variable
enamel hypoplasia or generalized thinning of the enamel which is what one would predict for
hemizygous affected males [Backman, 1988].
Four mutations in the 16 amino acid signal peptide have been identified. These mutations are
all thought to cause a loss of protein or cause the protein not to be secreted from the cell. All
signal peptide mutations identified to date result in a severe reduction in enamel thickness and
a clinical phenotype of smooth hypoplastic AI. The little enamel that is present is described as
hard and well-mineralized (Fig. 1).
AMELX Mutations in the N Terminus Coding Region
Four AMELX mutations involving part of the N-terminus of the amelogenin protein have been
described. The first of these was a frameshift mutation [Aldred et al., 1992b; Lench et al.,
1994] resulting from a single nucleotide substitution in exon 5 and the introduction of a
premature stop codon. This mutation is predicted to result in an amelogenin protein that is 36
amino acids in length. Both families described with this mutation show primarily a
hypomineralization/hypomaturation phenotype but also varying degrees of hypoplasia. There
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was marked phenotypic variability in the severity between same gender individuals even within
the same family [Aldred et al., 1992b; Lench et al., 1994].
Three missense mutations affecting the N-terminal region of the amelogenin protein involve
single nucleotide substitutions that cause single amino acid changes. One of these mutations
occurs in exon 5 (g.3455C >T) and produces a Threonine to Isoleucine change at amino acid
51 (p.T51I) [Lench and Winter, 1995]. The phenotype resulting from this one amino acid
change is described as hypomineralization/hypomaturation with brown discoloration of the
enamel. Similarly, two other mutations (P70T and H77L) that occur in exon 6 produce an
enamel phenotype classified as hypomaturation with brown discolored enamel (Fig. 2) [Collier
et al., 1997; Ravassipour et al., 2000; Hart et al., 2002]. All of these mutations cause changes
in the protein at or in close proximity to a region that has specific proteinase cleavage sites.
Studies have verified that the P70T change in amelogenin does cause a reduction in the ability
of MMP20 (the primary proteinase for processing amelogenin) to cleave the mutant protein
compared with wild type protein [Li et al., 2001].
AMELX Mutations in the C Terminus Coding Region
There are five different mutations that introduce a premature stop codon and truncate the C-
terminus of the amelogenin protein. Four of these mutations are single nucleotide deletions at
various locations in exon 6. All introduce a premature stop codon at amino acid position 187
[Lench and Winter, 1995; Kindelan et al., 2000; Sekiguchi et al., 2001; Hart et al., 2002]. The
amelogenin proteins produced by these four mutations are similar in that all lack the C-terminal
18 amino acids. However, they all differ in the extent and type of amino acid changes occurring
between the point of the deletion and the stop codon. One AMELX mutation introduces a single
nucleotide change (c.571G >T) and a premature stop codon late in exon 6 (p.E191X), causing
truncation of the protein at position 191. This results in a secreted amelogenin protein 14 amino
acids shorter than the wild type [Lench and Winter, 1995]. Despite these differences, all
mutations evaluated to date that affect the C-terminus of the amelogenin protein are associated
with a generalized thinning of the enamel and a smooth hypoplastic phenotype (Fig. 3). The
C-terminus is known to have an affinity for forming enamel crystallites [Shaw et al., 2004]
and likely plays a critical role in amelogenin scaffold assembly during enamel development.
AUTOSOMAL DOMINANT AMELOGENESIS IMPERFECTA
ENAM Mutations: Genotype and Phenotype
In addition to amelogenin there are numerous other extracellular matrix components in
developing enamel, including proteins such as ameloblastin, enamelin and proteinases that are
required to process the matrix proteins during mineralization and are coded by genes on
autosomes [Krebsbach et al., 1996; Smith, 1998; Hu et al., 2000]. The first molecular defect
associated with an autosomal AI type was identified as a mutation in the enamelin coding gene
(ENAM) located on chromosome 4q21 [Rajpar et al., 2001]. Enamelin is considered to be an
enamel-specific protein secreted by ameloblasts and is localized at the secretory face of the
cell [Fukae et al., 1993]. Enamelin is a glycosylated protein secreted in relatively low amounts
(1–5% of matrix) [Yamakoshi et al., 1998; Hu et al., 2001]. While the specific role of enamelin
in amelogenesis is unknown, it is thought to be involved in crystallite growth regulation and
crystallite elongation.
Two clinically distinct forms of autosomal dominant AI, smooth hypoplastic AI and local
hypoplastic AI (OMIM 104500), are associated with multiple allelic ENAM mutations (Table
II) [Rajpar et al., 2001;Mardh et al., 2002]. The clinically distinct phenotypes resulting from
these allelic mutations are hypothesized to result from haploinsufficiency in the local
hypoplastic type and from a dominant negative effect in the more severe generalized
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hypoplastic type [Mardh et al., 2002]. The local hypoplastic phenotype resulting from
ENAM mutations that essentially stop protein production from one allel is characterized by
horizontal bands of hypoplastic pits that encompass the tooth (Fig. 4). In contrast, mutations
that result in a secreted but altered protein are associated with a generalized thin hypoplastic
phenotype (Fig. 5) where close evaluation often reveals fine horizontal bands and pitting on
the surface of the enamel.
Autosomal Dominant Hypocalcified AI
The most common form of AI in North America is thought to be the autosomal dominant
hypocalcified type although current epidemiological studies are lacking [Witkop, 1957]. The
molecular etiology for this AI type remains unknown at this time. However linkage studies in
two large kindreds have excluded all known AI candidate genes as causative in these two
families (i.e., tuftelin, enamelin, ameloblastin, kallikrien 4, and enamelysin) [Hart et al.,
2003].
This indicates that there are additional, as yet undiscovered genes associated with autosomal
dominant AI.
Autosomal Dominant Hypoplastic Hypomaturation AI With Taurodontism
Whether or not autosomal dominant hypoplastic hypomaturation AI with taurodontism
(ADHHAI) is truly a distinct entity has been controversial [Crawford and Aldred, 1990; Seow,
1993]. Many of the cases reported as ADHHAI were later found to be the autosomal dominant
condition named for its three principally affected tissues (hair, teeth, and bones), tricho-dento-
osseous syndrome (TDO, OMIM 190320) [Crawford and Aldred, 1990; Wright et al., 1997].
The molecular etiology of TDO was discovered to involve a four base pair deletion in the distal-
less 3 homeobox gene (DLX3 located at chromosome 17q21) [Price et al., 1998]. One family
having the ADDHHAI with taurodontism phenotype was evaluated and showed no mutations
in the coding or splice site regions of the DLX3 gene suggesting ADDHHAI with taurodontism
is indeed a distinct entity [Price et al., 1999]. Recently a new DLX3 mutation involving a two
base pair deletion in the homeobox region of the gene was reported as being associated
ADDHHAI with taurodontism [Dong et al., 2005]. While the family members clearly showed
the characteristic dental phenotype of thin discolored enamel and enlarged pulp chambers, they
lacked a hair or bone phenotype. Investigation of an additional family having the same
DLX3 CT deletion revealed, through careful phenotype analysis, that while not having the
characteristic kinky curly hair associated with the DLX3 4 base pair deletion, all affected
members did have a distinct hair phenotype. Hair of individuals having the DLX3 CT deletion
was unmanageable, had a significantly smaller shaft diameter, and frequently displayed vertical
grooves similar to those observed in hair shafts of individuals with the DLX3 four base pair
deletion. The bone phenotype associated with the DLX3 CT deletion mutation is either not
present or appears much milder compared with the four base pair deletion affected individuals.
Careful bone phenotypic studies have not yet been completed. The presence of a hair and tooth
phenotype associated with the DLX3 CT deletion indicates this mutation is associated with a
mild expression of TDO and not ADDHHAI. The molecular defect for ADDHHAI with
taurodontism remains to be discovered.
AUTOSOMAL RECESSIVE AMELOGENESIS IMPERFECTA
Two well characterized forms of AI are associated with the major proteinases responsible for
processing the enamel extracellular matrix during enamel development [Hu et al., 2002].
Enamelysin, a matrix metalloproteinase (coded by the MMP20 gene), is secreted most
abundantly during the secretory stage of development and processes amelogenin in a highly
controlled fashion [Bartlett and Simmer, 1999]. Kalikrien four (formally known as enamel
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matrix serine proteinase 1, EMSP1), is a serine proteinase (coded by the KLK4 gene) and is
secreted most abundantly during the maturation stage. KLK4 can cleave a variety of proteins
and is thought to be responsible for removing the matrix proteins almost entirely to allow final
growth of the enamel crystallites [Simmer and Hu, 2002]. Mutations in both of these
proteinases are associated with pigmented hypomaturation AI (OMIM 204700) and enamel
that is not mineralized to its full extent and shows increased protein retention (Table III). One
kindred has been described with an autosomal recessive mode of inheritance for an ENAM
mutation [Kim et al., 2005b] that is associated with a phenotype similar to the dominant
negative ENAM mutation phenotypes.
Enamelysin (MMP20) Mutations: Genotype and Phenotype
Enamelysin (coded by the MMP20 gene) is considered to be a tooth specific matrix
metalloproteinase. Two mutations have been identified in this gene that purportedly would
cause loss of function. Both MMP20 mutations are associated with the pigmented
hypomaturation AI phenotype characterized by enamel that has a reduced mineral content
[Kim et al., 2005b]. The teeth have an orange–brown coloration, have a normal enamel
thickness, and the enamel lacks its normal radioopacity showing little contrast when compared
with dentin (Fig. 6).
Kalikrein 4 Mutations: Genotype and Phenotype
The enamel phenotype observed with KLK4 mutation [Hart et al., 2004] is consistent with a
loss of protein function critical for its purported role in enamel mineralization and its known
temporal and spatial expression [Simmer and Hu, 2002]. The transcript produced by the g.
2142G >A mutation would result in a 153 amino acid protein that lacks the S207 of the catalytic
triad that is essential for proteolytic activity [Hart et al., 2004]. The truncated product would
also lack the conserved asparagine and glycine encoded by exon 6 that characterize the binding
pocket that defines substrate specificity [Komatsu et al., 2003].
Teeth from the affected individuals have a marked orange–brown coloration in both the primary
and permanent dentitions (Fig. 7). Radiographically, the teeth have normal morphology with
enamel that has a decreased radiodensity compared with normal teeth. The enamel crystallites
appear to have increased space between them and the enamel has an increased retention of
amelogenin-like protein.
DISCUSSION
Evaluation of the phenotype and genotype relationship in AI suggests there is clustering of
phenotypes depending on the specific gene involved, the type of mutation and its effect on the
translated protein, and the protein functional properties. The demarcation between phenotypes
is not always exact with some overlap occurring between hypoplastic and hypomineralization
defects [Wright et al., 2003]. This is not surprising given that AI genes and their associated
proteins are involved in related pathways critical to the secretion, organization, processing,
and/or mineralization of the developing enamel.
Four genes (AMELX, ENAM, KLK4, and MMP20) and 23 different mutations have been
reported in the literature to date. Most of the identified allelic mutations are in the AMELX
gene, although the two proteinase gene mutations were discovered only recently. While four
genes have been associated with different AI types, there are other candidate genes proposed
that have not, as yet, been related to an AI phenotype. Ameloblastin, the second most abundant
protein in the enamel matrix is coded for by the AMBN gene [Krebasbach et al., 1996]. No
human mutations in the AMBN gene have been associated with AI. However, based on the
marked hypoplastic enamel phenotype in Ambn null mice [Fukumoto et al., 2004] it appears
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clear that this protein is critical for normal enamel formation. Negative linkage studies of
kindreds with autosomal dominant hypocalcified AI indicate that genes other than the
candidates proposed to date are also involved in AI. Collectively, these studies continue to
indicate that genetic heterogeneity and phenotypic diversity are greater than one might have
predicted based on classifications recognizing four main types and 14 subtypes.
Clinicians involved in diagnosing and managing these diverse conditions should be familiar
with the different phenotypes and associated inheritance patterns. This information is critical
for helping to narrow the search for a candidate gene so that a definitive molecular etiology
can be established. There are some phenotypes that are so distinct, such as the ENAM associated
local hypoplastic phenotype (horizontal bands of enamel pits), that the gene of major effect
can often be effectively predicted. This also has proven true for the AMELX P70T mutation
which produces a distinctly discolored hypomaturation phenotype where the cervical areas of
the teeth are opaque white and the coronal portions of the teeth are brown.
However, in many cases having knowledge of the phenotype without information of the likely
mode of inheritance pattern will often be insufficient to pursue a meaningful and informative
molecular study. For example, a hypomaturation phenotype can be associated with multiple
modes of inheritance and known genetic mutations such as an autosomal recessive trait
(KLK4 or MMP20 mutation) or X-linked hypomaturation AI (AMELX mutations). A
hypoplastic phenotype could be caused by X-linked (AMELX 5 prime, major deletion or 3
prime mutations), autosomal recessive (ENAM), or dominant (ENAM) mutations. As new genes
are identified there is a high probability that they will have phenotypes that overlap the known
clinical phenotypes making molecular identification even more complicated.
Since AI was first described there have been numerous nomenclatures proposed and in recent
years much discussion about a molecular based nosology [Winter and Brook, 1975; Witkop,
1989; Aldred et al., 2003]. Although this would appear to be an obvious direction for future
delineation of these clinically and genetically diverse conditions, it is as yet unclear how
merging mode of inheritance, phenotypic information, and molecular basis of the condition
can be best achieved. Future nomenclatures must be robust enough for effective
communication between clinicians, geneticists, and researchers. Given the need for
information about the mode of inheritance and phenotype necessary to pursue meaningful
molecular studies, the adoption of a nomenclature that is predicated on the inheritance and
phenotype, with further delineated of the molecular basis, appears to be the most useful at this
time [Nussier et al., 2004]. This is in contrast to the nomenclature proposed by Witkop that is
predicated on phenotype followed by mode of inheritance [Witkop, 1989]. The emerging
complexity and heterogeneity of AI will likely require a consortium of experts to establish a
more useful and meaningful nosology as our knowledge of these diverse hereditary defects of
enamel continues to expand.
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Loss of amelogenin due to signal peptide mutations results in a marked reduction in enamel
thickness as seen in this male with a p.M1T mutation. The teeth are relatively normal in color
and slightly reduced in size and the extremely thin enamel can be more readily visualized on
the dental radiographs [Kim et al., 2004]. [Color figure can be viewed in the online issue, which
is available at www.interscience.wiley.com.]
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Point AMELX mutations altering the tyrosine rich region of the amelogenin protein cause
hypomaturation of the enamel producing the characteristic white cervical opaque and coronal
brown discoloration of the enamel, as seen in this male with a P70T mutation. [Color figure
can be viewed in the online issue, which is available at www.interscience.wiley.com.]
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AMELX mutations affecting the C-terminus of the amelogenin protein cause a marked
generalized decrease in enamel thickness in males (A) and produces vertical grooves in females
due to Lyonization, as seen in the dentition of this heterozygous female (B). [Color figure can
be viewed in the online issue, which is available at www.interscience.wiley.com.]
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Autosomal dominant ENAM mutations associated with haploinsufficiency produce a local
hypoplastic phenotype characterized by horizontal bands of pits that occur at the same height
on the crowns of all teeth despite their marked difference in chronological development as seen
in the teeth of this affected individual [Mardh et al., 2002]. [Color figure can be viewed in the
online issue, which is available at www.interscience.wiley.com.]
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The generalized thin enamel in this affected individual has a rough pitted surface that results
from an ENAM mutation producing a dominant negative affect. [Color figure can be viewed
in the online issue, which is available at www.interscience.wiley.com.]
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The autosomal recessive pigmented hypomaturation phenotype produced by a MMP20
mutation characterized by teeth that have reduced mineral content and have a white-to-brown
discoloration [Kim et al., 2005b]. [Color figure can be viewed in the online issue, which is
available at www.interscience.wiley.com.]
Wright Page 16














Autosomal recessive pigmented hypomaturation resulting from a KLK4 mutation is
characterized by enamel of normal thickness that has a marked orange–brown discoloration,
as seen in this affected female. [Color figure can be viewed in the online issue, which is
available at www.interscience.wiley.com.]
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Genomic DNA cDNA Protein Male phenotype Reference
g.2T >C c.2T >C p.M1T Smooth hypoplastic (normal
mineralization)
Kim et al. [2004]
g.11G >C c.11G >C p.W4S Smooth hypoplastic (normal
mineralization)
Kim et al. [2004]
g.11G >A c.11G >A p.W4X Smooth hypoplastic (normal
mineralization)
Sekiguchi et al. [2001]




g.1148_54del c.55_54del p.18del Hypomaturation (some hypoplasia) Lagerström et al. [1991]
g.3455C >T c.152C >T p.T51I Hypomaturation (some hypoplasia) Lench and Winter
[1995]
g.3458delC c.155delC p.P52fsX53 Hypomaturation (some hypoplasia,
variable)
Aldred et al. [1992b];
Lench et al. [1994]
g.3781C >A c.208C >A p.P70T Hypomaturation (some hypoplasia) Collier et al. [1997];
Hart et al. [2000]
g.3803A >T c.230A >T p.H77L Hypomaturation Hart et al. [2002]
g.3958delC c.385delC p.H129fsX187 Smooth hypoplastic Sekiguchi et al. [2001]
g.3993delC c.420delC p.Y141fsX187 Smooth hypoplastic Greene et al. [2002]
g.4046delC c.473delC p.P158fsX187 Smooth hypoplastic Lench and Winter
[1995]
g.4114delC c.541delC p.L181fsX187 Smooth hypoplastic (some
hypomineralization)
Kindelan et al. [2000];
Hart et al. [2001]
g.4144G >T c.571G >T p.E191X Smooth hypoplastic Lench and Winter
[1995]
















Genomic DNA cDNA Protein Phenotype Reference
g.2382A >T c.157A >T p.K53X Local hypoplastic Mardh et al. [2002]
g.6395G >A IVS7 +1G >A; c.534
+1G >A
p.A158_Q178del Generalized thin hypoplastic Rajpar et al. [2001]
g.8344delG IVS8 +1delG; c.588
+1delG
p.N197fsX277 Generalized thin hypoplastic Kida et al. [2002];
Hart et al. [2003]
g.13185_13186insAG c/1258_1259insAG p.P422fsX448 Generalized thin hypoplastic Hart et al. [2004]















MMP20 and KLK4 Mutations
Genomic DNA cDNA Protein Phenotype Reference
MMP20 Mutations
g.30561A >T c.954-2A >T or
c.IVS6-2A-T
p.I319Fs338X or p.I319X Pigmented
hypomaturation
decreased mineral
Kim et al. [2005]
g.16250T >A c.678T >A p.H226Q Hypomaturation Ozdemir et al.
[2005]
KLK4 Mutations
g.2142G >A c.458G >A p.W153X Pigmented
hypomaturation
decreased mineral
Hart et al. [2004]
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